TABLE 5.

Comparison of clinical outcomes of patients with positive multi-drug resistant organism.

	AMS (n = 58)	Pre-AMS (n = 90)	p-value
Primary outcomes
Use of Polymyxin (≥2 days), n (%)	9 (15.52)	28 (31.11)	0.034
DOT of Polymyxin (day/patients), mean (SD)	11.00 ± 5.07	13.18 ± 7.64	0.431
Use of Tigecycline (≥2 days), n (%)	2 (3.45)	10 (11.11)	0.127
DOT of Tigecycline (day/patients), mean (SD)	5.00 ± 2.83	8.50 ± 5.91	0.445
Secondary outcomes, n (%)
Mortality	13 (22.41)	24 (26.67)	0.698
All-cause readmission	7 (12.07)	4 (4.4)	0.111
Readmission due to the same cause as the previous admission	2 (3.45)	0 (0)	0.152
Prescription adjustment number (mean, IQR),items	3 (3,4)	2 (2,3)	<0.001
Appropriate de-escalation	23 (39.66)	18 (20.00)	<0.001
Adverse drug reactions	7 (12.07)	18 (20%)	0.264